Test Price
2,800 AED✅ Home Collection Available
ZBTB16 Gene Sequencing (NGS) – Skeletal Defects, Genital Hypoplasia & Intellectual Disability Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Diagnostic Sensitivity: 99.9% via ISO‑certified processing
- Sample Collection: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (daily 8 AM – 11 PM)
- Post‑test Guidance: Telephonic consultation with a genetic specialist to interpret results
- Insurance: Direct verification and billing support via WhatsApp at +971 54 548 8731
Test Overview & Methodology
This advanced Next‑Generation Sequencing (NGS) test analyzes the ZBTB16 gene to detect pathogenic variants causing skeletal defects, genital hypoplasia, and intellectual disability. It provides a definitive molecular diagnosis, enabling targeted management, educational planning, and reproductive counselling. The assay is performed on peripheral blood, extracted DNA, or dried blood spot (FTA card) with a turnaround of 3–4 weeks.
| Parameter | Our Test (NGS) | Alternative (Clinical Evaluation) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity | Low molecular confirmation |
| Method | NGS on blood / DNA / FTA card | Phenotypic assessment, imaging |
| Speed | 3–4 weeks | Variable, often delayed |
Physician Insight & Safety Protocols
“I understand how challenging it can be for families to navigate genetic testing. This ZBTB16 gene sequencing provides critical molecular evidence, but it must be interpreted alongside a thorough clinical evaluation and family history. Please consult your geneticist or paediatrician before making any treatment decisions.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue any prescribed medication without consulting your doctor. This test is not a substitute for ongoing clinical care.
Exclusion Criteria & Red Flags
- Minors require consent from a legal guardian (aligned with UAE personal data protection laws).
- Not suitable for asymptomatic individuals without a clinical indication or prior genetic counselling.
- If the patient exhibits acute respiratory distress, severe dysmorphic crisis, or suspected metabolic decompensation, seek emergency care immediately—do not delay for test results.
Patient FAQ & Clinical Guidance
1. What is the ZBTB16 gene test and why is it important for my child?
The ZBTB16 gene test uses Next‑Generation Sequencing to detect pathogenic variants that cause skeletal defects, genital hypoplasia, and intellectual disability. Early identification allows for targeted management, educational planning, and reproductive counselling for the family.
2. How is the test performed and what sample is required?
A small blood sample, extracted DNA, or a dried blood spot on an FTA card can be collected at home by our certified phlebotomist, with results delivered in 3–4 weeks via a secure digital report. No special preparation is needed, but we recommend a prior genetic counselling session to draw a pedigree chart.
3. Is this test covered by insurance and what support is available?
We provide direct insurance billing verification via WhatsApp at +971 54 548 8731; our team checks your coverage and supplies a cost estimate before testing. After the test, a telephonic consultation is offered to help you interpret the results.
UAE Regulatory & Data Privacy Adherence
Legal & Compliance Framework
This test is conducted in full compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- Federal Decree-Law No. 4 of 2016 on Medical Liability
All patient data is encrypted, access‑controlled, and processed in accordance with UAE health data protection standards. Your privacy and safety remain our priority.
Clinical & Logistical Metadata
| Test Name | ZBTB16 Gene Sequencing (NGS) – Skeletal Defects, Genital Hypoplasia & Intellectual Disability |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood, extracted DNA, or dried blood spot (FTA card) |
| Methodology Used | Next‑Generation Sequencing (NGS) of the ZBTB16 gene |
| ICD-10-CM Code | Z13.79 |
| LOINC Code | 38075-4 |
| DHA Facility License & Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians